Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Page 1
Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): a prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trial.
Wu Z, Spencer LG, Banya W, Westoby J, Tudor VA, Rivera-Ortega P, Chaudhuri N, Jakupovic I, Patel B, Thillai M, West A, Wijsenbeek M, Maher TM, Smith JA, Molyneaux PL. Wu Z, et al. Among authors: banya w. Lancet Respir Med. 2024 Apr;12(4):273-280. doi: 10.1016/S2213-2600(23)00432-0. Epub 2024 Jan 15. Lancet Respir Med. 2024. PMID: 38237620 Free article. Clinical Trial.
Morphine shows promise as an effective treatment to palliate cough in patients with idiopathic pulmonary fibrosis, and longer term studies should be the focus of future research. FUNDING: The Jon Moulton Charity Trust....
Morphine shows promise as an effective treatment to palliate cough in patients with idiopathic pulmonary fibrosis, and longer term st …
Oral nitrate supplementation improves cardiovascular risk markers in COPD: ON-BC, a randomised controlled trial.
Alasmari AM, Alsulayyim AS, Alghamdi SM, Philip KEJ, Buttery SC, Banya WAS, Polkey MI, Armstrong PC, Rickman MJ, Warner TD, Mitchell JA, Hopkinson NS. Alasmari AM, et al. Among authors: banya was. Eur Respir J. 2024 Feb 1;63(2):2202353. doi: 10.1183/13993003.02353-2022. Print 2024 Feb. Eur Respir J. 2024. PMID: 38123239 Free PMC article. Clinical Trial.
BACKGROUND: Short-term studies suggest that dietary nitrate (NO(3) (-)) supplementation may improve the cardiovascular risk profile, lowering blood pressure (BP) and enhancing endothelial function. ...
BACKGROUND: Short-term studies suggest that dietary nitrate (NO(3) (-)) supplementation may improve the cardiovascular risk profile, …
Dietary nitrate supplementation to enhance exercise capacity in hypoxic COPD: EDEN-OX, a double-blind, placebo-controlled, randomised cross-over study.
Pavitt MJ, Lewis A, Buttery SC, Fernandez BO, Mikus-Lelinska M, Banya WAS, Feelisch M, Polkey MI, Hopkinson NS. Pavitt MJ, et al. Among authors: banya was. Thorax. 2022 Oct;77(10):968-975. doi: 10.1136/thoraxjnl-2021-217147. Epub 2021 Dec 1. Thorax. 2022. PMID: 34853156 Clinical Trial.
METHODS: We conducted a single-centre, double-blind, placebo-controlled, cross-over study, enrolling adults with COPD who were established users of long-term oxygen therapy. Participants performed an endurance shuttle walk test, using their prescribed oxygen, 3 hours after …
METHODS: We conducted a single-centre, double-blind, placebo-controlled, cross-over study, enrolling adults with COPD who were established u …
Impact of gastrointestinal comorbidities in patients with right and left atrial isomerism.
Fotaki A, Doughty VL, Banya W, Giuliani S, Bradley S, Carvalho JS. Fotaki A, et al. Among authors: banya w. Cardiol Young. 2022 Jul;32(7):1053-1060. doi: 10.1017/S1047951121003620. Epub 2021 Sep 2. Cardiol Young. 2022. PMID: 34470692
We assessed the spectrum of gut abnormalities and their impact on medium-term outcome in a cohort of patients with fetal and postnatal diagnoses of heterotaxy syndrome. ...Between 1 and 10 years of follow-up, the impact of gastrointestinal abnormalities on outcome was mini …
We assessed the spectrum of gut abnormalities and their impact on medium-term outcome in a cohort of patients with fetal and postnata …
Use of oscillatory positive expiratory pressure (OPEP) devices to augment sputum clearance in COPD: a systematic review and meta-analysis.
Alghamdi SM, Barker RE, Alsulayyim ASS, Alasmari AM, Banya WAS, Polkey MI, Birring SS, Hopkinson NS. Alghamdi SM, et al. Among authors: banya was. Thorax. 2020 Oct;75(10):855-863. doi: 10.1136/thoraxjnl-2019-214360. Epub 2020 Aug 11. Thorax. 2020. PMID: 32788259
Pooled analysis showed low-grade evidence that the use of OPEP devices was associated with decreased COPD symptoms and exacerbations (OR 0.37, 95% CI 0.19 to 0.72), and enhanced exercise capacity; 6 min walk distance (mean difference (95% CI), 49.8 m (14.2 m to 85.5 m); p=0.009]) …
Pooled analysis showed low-grade evidence that the use of OPEP devices was associated with decreased COPD symptoms and exacerbations (OR 0.3 …
5-Year Survival after Endobronchial Coil Implantation: Secondary Analysis of the First Randomised Controlled Trial, RESET.
Garner JL, Kemp SV, Srikanthan K, Caneja C, Zoumot Z, Roberts C, Banya W, Chaudhuri R, Bicknell S, Ross E, LaPrad AS, Shah PL. Garner JL, et al. Among authors: banya w. Respiration. 2020;99(2):154-162. doi: 10.1159/000505274. Epub 2020 Jan 22. Respiration. 2020. PMID: 31968351
Studies have demonstrated an acceptable safety profile and improvements in lung function, exercise capacity, and quality of life out to 3 years. Volume reduction is key. However, data for longer-term survival are limited. OBJECTIVE: The aim of this study was to establish t …
Studies have demonstrated an acceptable safety profile and improvements in lung function, exercise capacity, and quality of life out to 3 ye …
Management of concomitant coronary artery disease in patients undergoing transcatheter aortic valve implantation: the United Kingdom TAVI Registry.
Snow TM, Ludman P, Banya W, DeBelder M, MacCarthy PM, Davies SW, Di Mario C, Moat NE. Snow TM, et al. Among authors: banya w. Int J Cardiol. 2015 Nov 15;199:253-60. doi: 10.1016/j.ijcard.2015.06.166. Epub 2015 Jul 4. Int J Cardiol. 2015. PMID: 26209948
CONCLUSIONS: This contemporary study of coronary artery disease management in an "all-comers" patient population undergoing TAVI demonstrates that whilst often an indicator of significant underlying comorbidity coronary artery disease is not associated with decreased short or lon …
CONCLUSIONS: This contemporary study of coronary artery disease management in an "all-comers" patient population undergoing TAVI demonstrate …
Long-term outcomes after transcatheter aortic valve replacement in high-risk patients with severe aortic stenosis: the U.K. Transcatheter Aortic Valve Implantation Registry.
Duncan A, Ludman P, Banya W, Cunningham D, Marlee D, Davies S, Mullen M, Kovac J, Spyt T, Moat N. Duncan A, et al. Among authors: banya w. JACC Cardiovasc Interv. 2015 Apr 27;8(5):645-53. doi: 10.1016/j.jcin.2015.01.009. JACC Cardiovasc Interv. 2015. PMID: 25946435 Free article.
Device type, access route, and paravalvular leak did not independently predict long-term outcome. CONCLUSIONS: In the large U.K. Transcatheter Aortic Valve Implantation Registry, long-term outcomes after TAVR are favorable with 3- and 5-year survival rates of 61.2% …
Device type, access route, and paravalvular leak did not independently predict long-term outcome. CONCLUSIONS: In the large U.K. Tran …
Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012.
Ludman PF, Moat N, de Belder MA, Blackman DJ, Duncan A, Banya W, MacCarthy PA, Cunningham D, Wendler O, Marlee D, Hildick-Smith D, Young CP, Kovac J, Uren NG, Spyt T, Trivedi U, Howell J, Gray H; UK TAVI Steering Committee and the National Institute for Cardiovascular Outcomes Research. Ludman PF, et al. Among authors: banya w. Circulation. 2015 Mar 31;131(13):1181-90. doi: 10.1161/CIRCULATIONAHA.114.013947. Epub 2015 Jan 30. Circulation. 2015. PMID: 25637628
The strongest independent procedural predictor of long-term mortality was periprocedural stroke (hazard ratio=3.00; P<0.0001). ...Although clinical profiles of enrolled patients remained unchanged, longer-term outcomes improved, and patients were discharged earli …
The strongest independent procedural predictor of long-term mortality was periprocedural stroke (hazard ratio=3.00; P<0.0001). ... …
16 results